Atlas Trials

Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Clinical trial NCT01328756 · COMPLETED

Trial details

NCT number
NCT01328756
Sponsor
Shire
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder (ADHD)
Start date
2011-07-07
Primary completion
2014-09-30
Enrollment
314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.